Icon plc Aktie
Icon plc Aktie
Was spricht für und gegen Icon plc in den nächsten Jahren?
Pro
Kontra
Rendite von Icon plc im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Icon plc | -2,67 % | 6,54 % | -7,48 % | 64,73 % | 11,49 % | - | - |
Alkermes plc | 0,89 % | 1,80 % | -8,87 % | -11,02 % | -9,60 % | 22,16 % | -14,39 % |
Sage Therapeutics Inc. | 2,86 % | 2,04 % | -26,58 % | -70,43 % | -36,13 % | -80,29 % | - |
Novocure Ltd | 1,61 % | 4,05 % | -18,35 % | -80,26 % | -17,27 % | -93,03 % | - |
Kommentare
News
ICON Reports First Quarter 2024 Results
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the first quarter ended March 31, 2024.
CEO, Dr
ICON Announces CFO Transition
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Chief Financial Officer, Brendan Brennan, will leave his role at ICON in
ICON plc Schedules First Quarter 2024 Earnings Conference Call
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that it will release its financial results for the first quarter 2024 after the